Arcturus Therapeutics Holdings Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of ARCT for the last quarter is 28.21 M USD, and it's 34.96% lower compared to the previous quarter. The net income of Q4 23 is -8.57 M USD.